excess mucus or phlegm (DBCOND0097514)
Identifiers
- Synonyms
- Not Available
Associated Data
- Indicated Drugs and Targets
Drug Description Targets Albuterol A beta-2 adrenergic receptor agonist used to treat asthma, bronchitis, COPD, as well as prevent exercise induced bronchospasms.Ammonium carbonate An expectorant indicated to treat a cough and phlegm.No drug targets Ammonium chloride Expectorant in cough syrups. The ammonium ion (NH4+) in the body plays an important role in the maintenance of acid-base balance. The kidney uses ammonium (NH4+) in place of sodium...No drug targets Brompheniramine A histamine H1 antagonist used to treat coughs, upper respiratory symptoms, and nasal congestion associated with allergies and the common cold.Carbocisteine A expectorant mucolytic used in the relief of respiratory of COPD and other conditions associated with increased mucus viscosity.Chlorpheniramine A histamine-H1 receptor antagonist indicated for the management of symptoms associated with upper respiratory allergies.- Histamine H1 receptortarget
- Cytochrome P450 3A4enzyme
- Cytochrome P450 2D6enzyme
- Sodium-dependent serotonin transportertarget
- Sodium-dependent noradrenaline transportertarget
- Sodium-dependent dopamine transportertarget
- Cytochrome P450 3A5enzyme
- Cytochrome P450 3A7enzyme
- Solute carrier family 22 member 2transporter
- Solute carrier family 22 member 1transporter
Erdosteine A mucolytic agent used to treat conditions characterized by pathological mucus such as respiratory tract infections and chronic obstructive pulmonary disease (COPD).Guaifenesin An expectorant commonly found in OTC products for the symptomatic relief from congested chests and coughs associated with cold, bronchitis, and/or other breathing illnesses.- NMDA receptortarget
Phenylpropanolamine A sympathomimetic that was previously used in nasal decongestants and weight loss products, but has been withdrawn by the FDA due to safety risks and lack of efficacy.- Clinical Trials
- Not Available